
Neeraj Agarwal and Rana McKay
Jun 5, 2025, 15:32
Neeraj Agarwal Highlighted ASCO 2025 Presentation by Rana McKay on ETCTN Trial in mCRPC
Neeraj Agarwal, Postdoctoral fellow at City of Hope, shared a post on X:
“Stellar presentation at ASCO 2025 by trailblazer Rana McKay on ETCTN trial with radium +|- olaparib in mCRPC prostate cancer rPFS with the combo with/without HRRm.
Data continues to reinforce role of PARPi in rationale combinations,
Toni Choueiri – mentor.”
Read OncoDaily’s Special Articles about ASCO 2025:
Highlights from ASCO 2025 Day 1
Highlights from ASCO 2025 Day 2
Highlights from ASCO 2025 Day 3
Highlights from ASCO 2025 Day 4
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 5, 2025, 15:07
Jun 5, 2025, 12:10